Vision restoration therapies
The company develops these therapies for people with degenerative retinal diseases, independent of genetic mutation.
Source: LinkedIn company description · Retrieved October 13, 2026
Ray Therapeutics is a clinical-stage biotechnology company developing vision restoration therapies for people with degenerative retinal diseases, regardless of genetic mutation.
The company uses optogenetics to reprogram surviving retinal neurons to sense light and send visual signals to the brain. Its optogenetic medicine programs address a range of degenerative retinal diseases and are in preclinical and clinical development.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company develops these therapies for people with degenerative retinal diseases, independent of genetic mutation.
Source: LinkedIn company description · Retrieved October 13, 2026
The company is advancing programs for a range of degenerative retinal diseases in preclinical and clinical development.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 2, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 20, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.